|
|
Volumn 353, Issue , 2016, Pages i3421-
|
|
NICE approves immunotherapy combination for advanced melanoma
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IPILIMUMAB;
MONOCLONAL ANTIBODY;
NIVOLUMAB;
DRUG APPROVAL;
DRUG COST;
ECONOMICS;
HUMAN;
IMMUNOTHERAPY;
MELANOMA;
PROCEDURES;
SKIN NEOPLASMS;
UNITED KINGDOM;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DRUG APPROVAL;
DRUG COSTS;
HUMANS;
IMMUNOTHERAPY;
MELANOMA;
SKIN NEOPLASMS;
UNITED KINGDOM;
|
|
EID: 85013781687
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.i3421 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|